Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients: a Randomized Crossover Trial

NCT06381947 is registered in ClinicalTrials.gov with University of Salerno as lead sponsor.

NCT NCT06381947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06381947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients: a Randomized Crossover Trial
Lead sponsor
University of Salerno
Phase
Phase 4
Overall status
Unknown status
Start date
May 1, 2024
Completion date
June 30, 2025
Enrollment
130 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, dyslipidemias, lipid metabolism disorders, statin adverse reaction